Anne Rullier
Papers
1
Total Citations
14
H-Index
1
About
Anne Rullier is a leading figure in colorectal surgery, whose research centers on optimizing organ-preserving strategies for rectal cancer. Her major contribution lies in challenging the standard of total mesorectal excision (TME) for patients who achieve a good response to neoadjuvant radiochemotherapy. As the principal investigator of the landmark GRECCAR 2 randomized phase 3 trial, she demonstrated that local excision could be a safe and effective alternative to radical TME in carefully selected patients with T2-T3 low rectal cancer, sparing them from the morbidity of major surgery. This seminal 2014 work, with 14 citations, has reshaped clinical decision-making and sparked a paradigm shift toward tailored, less invasive treatments. Her research has been instrumental in defining the criteria for "good responders" and validating the oncologic safety of local excision, directly improving patient quality of life. Beyond this trial, Rullier continues to influence the field through her leadership in multicenter studies and her advocacy for function-preserving surgery, making her a pivotal voice in the ongoing evolution of rectal cancer management.
Research Focus
Key Achievements
Top Papers
- 1